Gavin Wood Adaptimmune Therapeutics PLC (ADAP) insider trading activity
Gavin Wood is Chief Financial Officer of Adaptimmune Therapeutics PLC. Currently has a direct ownership of 96,000 shares of ADAP, which is worth approximately $56,640. The most recent transaction as insider was on May 20, 2022, when has been sold 39,000 shares (Ordinary Shares with a nominal value of GBP0.001 per share) at a price of $0.29 per share, resulting in proceeds of $11,310. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
96K
0%
3M change
0%
12M change
Total Value Held
$56,640
Gavin Wood Transaction History
GW
Gavin Wood
Chief Financial Officer
Abingdon, X0